Full Picture

Extension usage examples:

Here's how our browser extension sees the article:
Appears strongly imbalanced

Article summary:

1. The Kangmei Pharmaceutical case has highlighted the need to improve the obligations and responsibilities of independent directors in China's corporate governance system.

2. International experience, particularly that of the United States, can provide valuable insights into how to improve the legal liability system for independent directors in China.

3. Rather than limiting the scope of independent director duties, China should focus on optimizing responsibility standards and maintaining appropriate responsibility pressure to encourage companies to select outstanding independent directors who can play a role in market signaling and corporate governance. This can be achieved through reforms to company law and securities law, improvements to the obligation system of independent directors, and the introduction of directors' liability insurance with a liability limit set at 5 times the total remuneration received by independent directors from the company.

Article analysis: